Found 4 matching trials
A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
PHASE1* To evaluate the safety and tolerability of ERAS-007 monotherapy administe...
Status
Active Not Recruiting
Location
Sarah Cannon Research Institute (HealthONE)
A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC
PHASE1* To evaluate the safety and tolerability of escalating doses of ERAS-007 o...
A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Hematologic Malignancies
PHASE1* To evaluate the safety and tolerability of escalating doses of ERAS-007 o...
Location
University of California San Francisco
A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies
PHASE1* To evaluate the safety and tolerability of escalating doses of ERAS-007 i...
Location
University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center)